Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction

Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405.
No abstract available

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology
  • Animals
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / immunology*
  • Fas Ligand Protein
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / physiology
  • Humans
  • Leukemia, T-Cell / immunology
  • Leukemia, T-Cell / pathology
  • Lymphoproliferative Disorders / genetics
  • Lymphoproliferative Disorders / immunology
  • Membrane Glycoproteins / physiology*
  • Models, Immunological
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Receptors, Tumor Necrosis Factor / physiology
  • fas Receptor / genetics
  • fas Receptor / physiology*

Substances

  • Antineoplastic Agents
  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Receptors, Tumor Necrosis Factor
  • fas Receptor